NCT02535000View on ClinicalTrials.gov

Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

October 20, 2015

Study Completion Date

October 30, 2015

Conditions
Intervertebral Disc Degeneration
Interventions
DRUG

Duloxetine

duloxetine 60 mg

DRUG

Placebo

placebo

All Listed Sponsors
lead

Serviço de Anestesiologia de Joinville

OTHER

NCT02535000 - Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery | Biotech Hunter | Biotech Hunter